Suppr超能文献

儿童和青少年幽门螺杆菌感染与免疫性血小板减少性紫癜:一项随机对照试验。

Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial.

作者信息

Brito Helena Shino Hanai, Braga Josefina Aparecida Pellegrini, Loggetto Sandra Regina, Machado Rodrigo Strehl, Granato Celso Francisco Hernandes, Kawakami Elisabete

机构信息

Division of Pediatric Gastroenterology, Department of Pediatrics, Escola Paulista de Medicina/Universidade Federal de São Paulo , São Paulo, SP , Brazil .

出版信息

Platelets. 2015;26(4):336-41. doi: 10.3109/09537104.2014.911836. Epub 2014 May 15.

Abstract

Helicobacter pylori and immune thrombocytopenic purpura (ITP) association is not well established in chronic ITP (cITP) in children, although the cure of thrombocytopenia in approximately half of H. pylori eradicated adult patients has been described. The aim of this study was to investigate the effect of H. pylori eradication on platelet (PLT) recovery in cITP children and adolescents through a randomized, controlled trial. A total of 85 children (mean age 11.4 years) with cITP were prospectively enrolled. Diagnosis of H. pylori was established by two locally validated tests, (13)C-urea breath test and monoclonal stool antigen test. Twenty-two infected patients were identified, and randomly allocated into two groups: H. pylori treatment group (n = 11) and the non-intervention control group (n = 11). The control group was offered treatment if the thrombocytopenia persisted after the follow-up. At baseline, there were no differences regarding age, sex, duration of disease, and PLT count between groups. Sixty three of 85 patients were uninfected. PLT response was classified as complete response: PLT > 150 × 10(9 )l(-1); partial response: PLT 50-150 × 10(9 )l(-1), or an increase of 20-30 × 10(9 )l(-1); no response: PLT < 50 × 10(9 )l(-1) or an increase of <20 × 10(9 )l(-1) after at least 6 months of follow-up. Complete response was observed in 60.0% (6/10, one excluded) H. pylori eradicated patients vs. 18.2% (2/11) in non-eradicated patients (p = 0.08; OR = 6.75) after 6-9 months of follow-up. Among uninfected patients, only 13.8% (8/58) presented complete response. Two non-treated controls were treated after 6-12 months of follow-up, and PLT response was observed in 61.5% (8/13) of H. pylori eradicated patients, and in 19.0% (11/58) of uninfected patients (p = 0.004). Cytotoxin associated gene A and vacuolating cytotoxin gene A IgG antibodies were present in almost all infected patients. Therefore, the study suggests that H. pylori eradication plays a role in the management of H. pylori infected cITP children and adolescents.

摘要

幽门螺杆菌与免疫性血小板减少性紫癜(ITP)的关联在儿童慢性ITP(cITP)中尚未完全明确,尽管已有报道称约一半根除幽门螺杆菌的成年患者血小板减少症得到治愈。本研究的目的是通过一项随机对照试验,探讨根除幽门螺杆菌对cITP儿童和青少年血小板(PLT)恢复的影响。前瞻性纳入了85例cITP儿童(平均年龄11.4岁)。通过两种本地验证的检测方法,即(13)C - 尿素呼气试验和单克隆粪便抗原试验,确定幽门螺杆菌感染情况。共识别出22例感染患者,并随机分为两组:幽门螺杆菌治疗组(n = 11)和非干预对照组(n = 11)。如果随访后血小板减少症持续存在,对照组将接受治疗。基线时,两组在年龄、性别、病程和PLT计数方面无差异。85例患者中有63例未感染。PLT反应分为完全缓解:PLT > 150×10⁹/L⁻¹;部分缓解:PLT 50 - 150×10⁹/L⁻¹,或增加20 - 30×10⁹/L⁻¹;无反应:PLT < 50×10⁹/L⁻¹或随访至少6个月后增加 < 20×10⁹/L⁻¹。随访6 - 9个月后,根除幽门螺杆菌的患者中60.0%(6/10,排除1例)出现完全缓解,未根除患者中为18.2%(2/11)(p = 0.08;OR = 6.75)。在未感染患者中,只有13.8%(8/58)出现完全缓解。2例未治疗的对照组在随访6 - 12个月后接受治疗,根除幽门螺杆菌的患者中有61.5%(8/13)出现PLT反应,未感染患者中为19.0%(11/58)(p = 0.004)。几乎所有感染患者均存在细胞毒素相关基因A和空泡毒素基因A IgG抗体。因此,该研究表明根除幽门螺杆菌在幽门螺杆菌感染的cITP儿童和青少年的治疗中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验